News | November 07, 2023
Sun Pharma Advanced Research posts Q2 FY24 loss at Rs. 86.42 Cr
Sun Pharma Advanced Research Company Limited has reported total income of Rs. 29.67 crores during the period ended September 30, 2023
Sun Pharma Advanced Research Company Limited has reported total income of Rs. 29.67 crores during the period ended September 30, 2023
The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
The newly developed adhesive is available in two different grades. Loctite WT 3001 and Loctite WT 3003 h
This product will be manufactured at Lupin's Nagpur facility in India
In 2022, darolutamide was FDA-approved in combination with docetaxel chemotherapy for adults with metastatic hormone-sensitive prostate cancer
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Lincoln Pharmaceuticals has reported total income of Rs. 164.68 crores during the period ended September 30, 2023
Sun Pharmaceutical Industries has reported total income of Rs. 12486.02 crores during the period ended September 30, 2023
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
The European Commission approved the use of Carbopol as an additive for liquid and solid food supplements in the EU
Subscribe To Our Newsletter & Stay Updated
